These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10748695)

  • 21. Psychiatric drugs and children.
    Jellinek MS
    Science; 2003 May; 300(5621):901. PubMed ID: 12738837
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe and uncommon involuntary movement disorders due to psychotropic drugs.
    Stübner S; Rustenbeck E; Grohmann R; Wagner G; Engel R; Neundörfer G; Möller HJ; Hippius H; Rüther E
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S54-64. PubMed ID: 15052515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Notification systems and adverse effect reporting].
    Aranaz Andrés JM
    Rev Calid Asist; 2009 Feb; 24(1):1-2. PubMed ID: 19369135
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pilot study for the surveillance of adverse reactions to herbal preparations and dietary supplements].
    Menniti-Ippolito F; Mazzanti G; Firenzuoli F; Bianchi A; Raschetti R
    Ann Ist Super Sanita; 2005; 41(1):39-42. PubMed ID: 16037648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project.
    Bousquet PJ; Demoly P; Romano A; Aberer W; Bircher A; Blanca M; Brockow K; Pichler W; Torres MJ; Terreehorst I; Arnoux B; Atanaskovic-Markovic M; Barbaud A; Bijl A; Bonadonna P; Burney PG; Caimmi S; Canonica GW; Cernadas J; Dahlen B; Daures JP; Fernandez J; Gomes E; Gueant JL; Kowalski ML; Kvedariene V; Mertes PM; Martins P; Nizankowska-Mogilnicka E; Papadopoulos N; Ponvert C; Pirmohamed M; Ring J; Salapatas M; Sanz ML; Szczeklik A; Van Ganse E; De Weck AL; Zuberbier T; Merk HF; Sachs B; Sidoroff A;
    Allergy; 2009 Feb; 64(2):194-203. PubMed ID: 19178398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cutaneous side effects due to psychiatric drugs].
    Rebok F; Pérez Roldán ML; Daray FM
    Vertex; 2008; 19(82):348-56. PubMed ID: 19424517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sensitivity to psychotropic drugs in schizophrenia].
    Poirier MF
    Encephale; 2002; 28 Spec No 1 Pt 2():S12-3. PubMed ID: 12486883
    [No Abstract]   [Full Text] [Related]  

  • 29. [Research on foreign countries laws and regulations on surveillance and reporting of postmarketing drugs adverse reactions].
    Tian F; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(11):1464-7. PubMed ID: 19771884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computerized surveillance of adverse drug events in hospital patients. 1991.
    Classen DC; Pestotnik SL; Evans RS; Burke JP
    Qual Saf Health Care; 2005 Jun; 14(3):221-5; discussion 225-6. PubMed ID: 15933322
    [No Abstract]   [Full Text] [Related]  

  • 31. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project.
    Stübner S; Padberg F; Grohmann R; Hampel H; Hollweg M; Hippius H; Möller HJ; Rüther E
    J Clin Psychiatry; 2000 Aug; 61(8):569-74. PubMed ID: 10982199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergency department visits for antibiotic-associated adverse events.
    Shehab N; Patel PR; Srinivasan A; Budnitz DS
    Clin Infect Dis; 2008 Sep; 47(6):735-43. PubMed ID: 18694344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting of fatal adverse drug reactions.
    Liu BA; Knowles SR; Mittmann N; Einarson T; Shear NH
    Can J Clin Pharmacol; 2001; 8(2):84-8. PubMed ID: 11493936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of an electronic medical record system for mandatory reporting of drug hypersensitivity reactions has been shown to improve the management of patients in the university hospital in Korea.
    Park CS; Kim TB; Kim SL; Kim JY; Yang KA; Bae YJ; Cho YS; Moon HB
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):919-25. PubMed ID: 18470952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of case reports of adverse drug reactions with psychotropic drugs: a 25-year review.
    Talat B; Mayers A; Baldwin DS
    Hum Psychopharmacol; 2013 Sep; 28(5):413-20. PubMed ID: 23754771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five fixes to improve drug safety. Ideas for how to prevent another Vioxx debacle.
    Thygeson M
    Minn Med; 2005 Dec; 88(12):36-7. PubMed ID: 16583524
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sweden can contribute to safer drug assessment].
    Strandberg K
    Lakartidningen; 2006 Jun 8-13; 103(23):1853-5. PubMed ID: 16838598
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES).
    Jhung MA; Budnitz DS; Mendelsohn AB; Weidenbach KN; Nelson TD; Pollock DA
    Med Care; 2007 Oct; 45(10 Supl 2):S96-102. PubMed ID: 17909391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.